Objective-The aim of this project was to test the hypothesis that redox factor 1 (Ref-1) was a critical upstream determinant of NF-B-dependent survival signaling pathways in the vessel wall.
R ecent insights into the underlying mechanisms of vascular disease have highlighted the central role of redox signaling, with a particular emphasis on NF-B. [1] [2] [3] Work from our group and others has demonstrated that Redox factor 1 (Ref-1) regulates DNA binding of multiple transcription factors, including NF-B. 4 -6 Specifically, upregulation of Ref-1 results in a significant increase in NF-B activity in vascular endothelial cells. 4 Moreover, recent work suggests that the reduction of the Cys-62 residue of p50 is essential for DNA binding activity of NF-B, and that Ref-1 is involved in the reduction of this critical residue. 7 Ref-1 (also known as APE, APEX, and HAP-1) was originally identified as a dual-acting transcription factor containing a redox-sensitive domain, as well as a DNA repair domain. 5,6,8 -12 Ref-1-null mice die during embryonic development and exhibit an abundance of fragmented and pyknotic nuclei, suggesting that Ref-1 plays a critical role in cell survival. 12 Based on these findings, we hypothesized that Ref-1 was a rate-determining factor governing NF-B activity and cell fate in the intact vasculature. To test this hypothesis, we used hemizygous mice harboring a single allele of Ref-1. We present evidence that hemizygosity for Ref-1 results in a significant reduction in NF-B activity in the aorta in parallel with a significant loss of the NF-B survival gene A20. A complementary Morpholino antisense approach to decrease Ref-1 expression in vitro resulted in a congruent loss of endothelial cell survival. Further analysis suggested that both the redox sensing domain and the AP endonuclease/DNA repair domain of Ref-1 are important in the regulation of endothelial cell survival. Using a biochemical approach, we demonstrate that the redox-sensing domain of Ref-1 is sufficient to reduce p50 and inhibit NF-B activity, whereas the AP endonuclease domain partially inhibits NF-B activity despite the fact that this region is not necessary to reduce p50. Taken together, these findings suggest that Ref-1 is an important mediator of NF-B signaling and survival in vascular endothelial cells.
Real-Time Quantitative Polymerase Chain Reaction
Real-time quantitative polymerase chain reaction was performed as we have previously described. 13 Primers and conditions are listed in online supplement.
Transfection
All transfections with expression vectors were performed in CPAE cells using a lipid-based transfection strategy (Effectene) as previously described. 4 .
Morpholino antisense oligodeoxynucleotides were transfected into cells according to the manufacturer's directions (GeneTools LLC.). Briefly, oligodeoxynucleotides (1.4 mol/L final concentration) were bound electrostatically to weakly basic ethoxylated polyethylenimine and endocytosed into the cell. Oligodeoxynucleotides included a Ref-1 antisense sequence 5ЈTTTTTCCCACGCTTCG-GCATTCCCG or an inverted control sequence 5ЈGCCCTTACG-GCTTCGCACCCTTTTT.
NF-B and AP-1 Transcriptional Activity
NF-B and AP-1 transcriptional activity were determined by transiently transfecting CPAE cells with the pNF-B-luciferase vector or the AP-1-luciferase vector along with pEGFP-C1, and pCB6-Ref-1, the Ref-1 redox-sensitive deletion mutant, or a control (pcDNA3.1) vector, as we have previously described. 4 EMSA NF-B DNA binding activity was determined by EMSA (Gel Shift Assay Kit; Promega) using the manufacturer's instructions except when noted (please see online supplement).
Western Blotting
SDS-PAGE and Western blotting were performed as we have previously described. 4, 13, 14 
Apoptosis
Both CPAE and HUVEC cells were grown on 6-well plates to near-confluence for all apoptosis experiments. Apoptosis was assessed by staining with the nuclear chromatin dye H33342 and quantifying the percentage of apoptotic nuclei in each sample (400 cells counted/sample) as we have previously described. 4, 13, 14 
Plasma Free F 2 -Isoprostanes
Plasma free F 2 -isoprostanes (a collection of isomers) were measured by a gas chromatography-mass spectrometry-based method as described. 15 
Expression and Isolation of Recombinant p50 and Ref-1 Proteins and F5 mol/L (Fluorescein-5-Maleimide) Experiments
The F5 mol/L blotting was performed as described by Nishi et al. 7 Briefly, recombinant p50 was treated with dithiothreitol (DTT), diamide, and recombinant wild-type Ref-1, the C-terminal deletion or N-terminal deletion Ref-1. In vitro assays were then performed on a gel and the reduced state of p50 determined by the increased binding of F5 mol/L to p50 as described by Nishi et al. 7 
Statistics
Comparisons between 2 groups were analyzed via a Student t test (PϽ0.05), whereas comparisons between 3 groups were analyzed by an analysis of variance (ANOVA) with a Student-Newman-Keuls post-hoc test (PϽ0.05); n refers to the total number of replicates in multiple experiments. Data are presented as meansϮSE.
Results
To In line with our hypothesis, CPAEs treated with the Ref-1 antisense sequence were significantly more susceptible to apoptosis under low serum conditions and tumor necrosis factor (TNF) compared with cells exposed to an inverted control sequence (low serum: inverted control sequence 9%Ϯ1% apoptotic nuclei; antisense to Ref-1, 18%Ϯ1% apoptotic nuclei; nϭ6; PϽ0.001) (TNF: inverted control sequence, 16%Ϯ1% apoptotic nuclei versus specific antisense sequence to Ref-1, 34%Ϯ2% apoptotic nuclei; nϭ6; PϽ0.001) (please see online supplement).
To determine whether the significant loss of the NF-B responsive survival gene A20 in the Ref-1ϩ/Ϫ vessel may be an important determinant governing the increase in susceptibility to endothelial cell apoptosis, we upregulated A20 and asked whether this was sufficient to block TNF-induced apoptosis. Upregulation of A20 significantly inhibited TNFinduced endothelial cell apoptosis (please see online supplement). Figure 4 ). Next, we performed a biochemical assay using fluorescein-5-maleimide (F5 mol/L) to define the ability of the deletion mutants to reduce cysteine residues in Next, we mutated residue C64 in Ref-1, a previously identified amino acid suspected to be necessary for NF-B regulation. 16 
Discussion
We have demonstrated that loss of Ref-1 significantly attenuates NF-B signaling in the intact vasculature. In parallel with the loss of NF-B signaling in Ref-1-deficient mice, expression of the NF-B-dependent survival gene A20 was significantly reduced, whereas IAP-2 and IL-6 were unchanged. Studies in isolated endothelial cells further corroborated the importance of Ref-1 in NF-B activation in response to TNF-␣ and demonstrated the importance of both the redox-sensitive and AP endonuclease domains in regulating NF-B activity. The redox-sensitive domain, but not the AP endonuclease domain, appears to stimulate NF-B through the reduction of p50. Loss of Ref-1 also led to a significant increase in F2 isoprostanes, a marker of oxidative stress, in the serum. This finding agrees with previous work. 17, 18 Loss of Ref-1 led to a significant increase in the susceptibility of endothelial cells to undergo apoptosis. The mechanism appears to be mediated in part through decreased stimulation of the pro-survival NF-B-A20 signaling cascade. Taken together, the evidence suggests that Ref-1 is an important upstream control point regulating NF-B signaling in response to TNF-␣ in the intact vessel, oxidative stress, and endothelial cell survival.
Ref-1 is a multifactorial protein involved in both DNA repair and redox-mediated transcriptional events, including the activation of NF-B. 4 -6,8 -12,16,19,20 The N-terminal 116 amino acid domain, partially absent in its bacterial homolog exonuclease III, has been shown to be responsible for its redox regulation, whereas the C-terminal domain is largely responsible for its DNA repair activity. 11 We demonstrated that both the N-and C-terminal domains for Ref-1 may be important for NF-B activity, as measured with our NF-B reporter assay. A limitation of this assay is the possible variation in deletion mutant expression. Thus, we chose to use a different biochemical technique using F5 mol/L to detect the ability of the Ref-1 deletion mutant recombinant proteins to reduce p50 levels. The goal was not to directly compare these two assays but to define the ability of Ref-1 itself and its mutants to reduce p50 as a potential mechanism defining how Ref-1 and the two mutants alter NF-B activity. These studies revealed that only the redox-sensitive domain . Future studies will be needed to address this issue.
Ref-1 has been shown to regulate several transcription factors in addition to NF-B, including AP-1, c-myb, p53, and members of the ATF/CREB family. 5, 6, 19, 20 Enhanced activation of AP-1 by Ref-1 has been described in several cell types. 5, 6, 22 We have reconfirmed this in endothelial cells. However, the role of AP-1 in regulating endothelial cell fate is not clear. [23] [24] [25] We also saw a decrease in AP-1 DNA binding in aortas of Ref-1 heterozygote mice compared with wild-type controls. Ref-1 has also been demonstrated to activate p53 and induce apoptosis in human tumor cell lines. 19 Given that we clearly document an anti-apoptotic effect of Ref-1 in response to TNF, it is unlikely that a pro-apoptotic effect via p53 is a major component of its effect in endothelial cells. Recent work by Angkeow et al demonstrated that Ref-1 overexpression in the setting of hypoxia promotes endothelial cell survival. 26 These findings are consistent with our previous work. 4 The ability of Ref-1 to promote survival in the setting of hypoxia does not appear to be mediated through NF-B. 4, 26 In fact, Angkeow et al reported that Ref-1 overexpression inhibited NF-B in the setting of hypoxia. 26 This fits with earlier work from our laboratory demonstrating that NF-B is not involved in mediating Ref-1-induced cell survival in the setting of hypoxia. 4 Work from our laboratory suggests that under hypoxic conditions, Ref-1 is likely inducing HIF-1a (unpublished findings from our laboratory). Taken together, these findings suggest that the ability of Ref-1 to bind to and regulate transcription factors is dependent on the environmental stimuli.
We found that loss of Ref-1 in the vessel wall correlated with a significant loss of LPS-stimulated NF-B activity, as well as a loss of the NF-B responsive survival gene, A20. Our interest in A20 stems from work by others demonstrating that A20 is a potent anti-apoptotic factor downstream of NF-B and serves as a feedback inhibitor to block NF-B activity. [27] [28] [29] [30] [31] Ferran et al have discussed the potential application of A20 as a therapeutic candidate. 29 Overexpression of A20 would protect endothelial cells from TNF-induced apoptosis while at the same time inhibiting NF-B through a negative feedback loop and thereby inhibiting inflammation. 29 To our knowledge, this is the first study to define a relationship between Ref-1 and A20. Future studies will be needed to further define the interplay between Ref-1, NF-B, A20, inflammation, and apoptosis in the vascular endothelium.
In conclusion, we have demonstrated that loss of Ref-1 leads to a significant increase in the susceptibility of vascular endothelial cells to undergo apoptosis. This effect appears to be mediated through the decreased stimulation of a prosurvival cascade involving NF-B and A20. Furthermore, previous work by our laboratory and others has demonstrated in gain-of-function experiments that increasing Ref-1 promotes survival to cytokine stress through increased NF-B activity. Taken together, these findings support previous work demonstrating a role for redox-related mechanisms in the regulation of NF-B and strengthen previous work defining a critical role of Ref-1 in mediating pro-survival signaling cascades in the vascular endothelium.
